Cite Filings / RNAC / 0001193125-23-276086
Feed Companies Filings Check
Sign in
10-Q

Quarterly Report

Cartesian Therapeutics, Inc. · Filed 2023-11-13 · Acc 0001193125-23-276086

Documents 1

  • 10-Q Quarterly Report , d549858d10q.htm

Around this filing

  • 2024-05-08 10-Q Quarterly Report
  • 2023-11-15 4 President and CEO returned 521,125 shares (to the company)
  • 2023-11-15 4 Options or other derivatives
  • 2023-11-13 10-Q Quarterly Report
  • 2023-11-13 DEFA14A Proxy Materials
  • 2023-11-13 8-K Material agreement · Acquisition or sale completed · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
  • 2023-08-17 10-Q Quarterly Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading d549858d10q.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…